Head of Growth

About Third Wave Third Wave educates the public on the importance of responsible and intentional psychedelic use. Our mission is to facilitate the world’s adoption of psychedelics as useful tools for healing and transformation. We do this through well-researched online content that is widely accessible and well-branded. Currently, we reach over 300K people per month, and have been featured in the BBC, Forbes, and the New York Times. With the rapid growth of interest in […]

Read more
Medical director

The Medical Director, reporting into the Chief Medical Officer, will join our Clinical Science team in London. We are looking for a highly motivated and experienced physician to join our Clinical Science team in London as a Medical Director. This role will report into the Chief Medical Officer. Responsibilities include (but are not limited to): Being actively involved in collaborative efforts between clinical trial sites and Clinical Operations to ensure the high-quality execution of all […]

Read more
Working Student – Science Analyst

ATAI is a Berlin, New York, and London based biotech company builder leveraging a decentralized, data-driven platform model with the aim of ultimately healing mental health disorders. We are dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively.  Our portfolio companies are developing innovative solutions in mental healthcare, including COMPASS Pathways […]

Read more
Independent Rater

MAPS Europe B.V., a trial sponsor, aims to obtain approval for the prescription use of 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy in patients with posttraumatic stress disorder (PTSD). MP18 is a multi-site, open-label, lead-in study that will assess the safety and effectiveness of MDMA-assisted psychotherapy in participants diagnosed with at least severe PTSD. The study will take place in multiple countries in Europe. Additional information about this research is available at mapseurope.eu. A group of […]

Read more